相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multi-Organ Protective Effects of Sodium Glucose Cotransporter 2 Inhibitors
Hidekatsu Yanai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic β cells in diabetic db/db mice
Yoshiro Fushimi et al.
SCIENTIFIC REPORTS (2021)
Glucolipotoxicity, β-Cells, and Diabetes: The Emperor Has No Clothes
Gordon C. Weir
DIABETES (2020)
SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action
Milton Packer
DIABETES CARE (2020)
Dysfunction of Persisting β Cells Is a Key Feature of Early Type 2 Diabetes Pathogenesis
Christian M. Cohrs et al.
CELL REPORTS (2020)
Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Decio L. Eizirik et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
Martin R. Cowie et al.
NATURE REVIEWS CARDIOLOGY (2020)
Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice
Rui Wei et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Differential effects of sodium-glucose cotransporter 2 inhibitor and low-carbohydrate diet on body composition and metabolic profile in obese diabetic db/db mice
Toru Kusakabe et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans
Heeyoung Chae et al.
MOLECULAR METABOLISM (2020)
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors A State-of-the-Art Review
Gary D. Lopaschuk et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients
Aino Latva-Rasku et al.
DIABETES CARE (2019)
No direct effect of SGLT2 activity on glucagon secretion
Rune E. Kuhre et al.
DIABETOLOGIA (2019)
Endoplasmic reticulum stress, degeneration of pancreatic islet β-cells, and therapeutic modulation of the unfolded protein response in diabetes
Rajarshi Ghosh et al.
MOLECULAR METABOLISM (2019)
Early administration of dapagliflozin preserves pancreatic β-cell mass through a legacy effect in a mouse model of type 2 diabetes
Ayumi Kanno et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Mechanisms of β-cell dedifferentiation in diabetes: recent findings and future research directions
Mohammed Bensellam et al.
JOURNAL OF ENDOCRINOLOGY (2018)
Protective Effect of Ipragliflozin on Pancreatic Islet Cells in Obese Type 2 Diabetic db/db Mice
Toshiyuki Takasu et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)
Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic β-cells in db/db mice: The earlier and longer, the better
Tomohiko Kimura et al.
DIABETES OBESITY & METABOLISM (2018)
Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus
Hussein Al Jobori et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
PANCREATIC beta-CELL ELECTRICAL ACTIVITY AND INSULIN SECRETION: OF MICE AND MEN
Patrik Rorsman et al.
PHYSIOLOGICAL REVIEWS (2018)
Effect of the sodium-glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages
Kiyohiko Takahashi et al.
SCIENTIFIC REPORTS (2018)
SGLT2 knockout prevents hyperglycemia and is associated with reduced pancreatic β-cell death in genetically obese mice
Michael J. Jurczak et al.
ISLETS (2018)
Sodium-glucose cotransporter-2 inhibition improves incretin sensitivity of pancreatic beta-cells in people with type 2 diabetes
Chang Ho Ahn et al.
DIABETES OBESITY & METABOLISM (2018)
Beneficial effects of sodium-glucose cotransporter 2 inhibitors for preservation of pancreatic β-cell function and reduction of insulin resistance
Hideaki Kaneto et al.
JOURNAL OF DIABETES (2017)
Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis
Chunguang Chen et al.
MOLECULAR METABOLISM (2017)
Metabolic Stress and Compromised Identity of Pancreatic Beta Cells
Avital Swisa et al.
FRONTIERS IN GENETICS (2017)
Pancreatic β-Cell Adaptive Plasticity in Obesity Increases Insulin Production but Adversely Affects Secretory Function
Cristina Alarcon et al.
DIABETES (2016)
Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes
Sumaira Z. Hasnain et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2016)
Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice
Seizo Okauchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Pancreatic β-cell identity in diabetes
M. S. Remedi et al.
DIABETES OBESITY & METABOLISM (2016)
The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin
Matthias Kern et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes
Sam Tsz Wai Cheng et al.
PLOS ONE (2016)
Dapagliflozin Lowers Plasma Glucose Concentration and Improves β-Cell Function
Aurora Merovci et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Dipeptidyl peptidase-4 inhibitor, vildagliptin, inhibits pancreatic beta cell apoptosis in association with its effects suppressing endoplasmic reticulum stress in db/db mice
Yan-ju Wu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
The balance between adaptive and apoptotic unfolded protein responses regulates β-cell death under ER stress conditions through XBP1, CHOP and JNK
Jeng Yie Chan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Proinsulin misfolding and endoplasmic reticulum stress during the development and progression of diabetes
Jinhong Sun et al.
MOLECULAR ASPECTS OF MEDICINE (2015)
Pancreatic β Cell Dedifferentiation in Diabetes and Redifferentiation following Insulin Therapy
Zhiyu Wang et al.
CELL METABOLISM (2014)
Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin
Sunder Mudaliar et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2014)
Reversible changes in pancreatic islet structure and function produced by elevated blood glucose
Melissa F. Brereton et al.
NATURE COMMUNICATIONS (2014)
The Sodium Glucose Cotransporter Type 2 Inhibitor Empagliflozin Preserves β-Cell Mass and Restores Glucose Homeostasis in the Male Zucker Diabetic Fatty Rat
Henrik H. Hansen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Glucotoxic conditions induce endoplasmic reticulum stress to cause caspase 3 mediated lamin B degradation in pancreatic β-cells: Protection by nifedipine
Khadija Syeda et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Influence of chronic hyperglycemia on the loss of the unfolded protein response in transplanted islets
Stacey N. Walters et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
Defects in beta cell Ca2+ signalling, glucose metabolism and insulin secretion in a murine model of KATP channel-induced neonatal diabetes mellitus
R. K. P. Benninger et al.
DIABETOLOGIA (2011)
Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight
L. Zhang et al.
DIABETES OBESITY & METABOLISM (2010)
Secondary Consequences of β Cell Inexcitability: Identification and Prevention in a Murine Model of KATP-Induced Neonatal Diabetes Mellitus
Maria Sara Remedi et al.
CELL METABOLISM (2009)
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Ralph A. DeFronzo
DIABETES (2009)
Pancreatic β-cell mass in European subjects with type 2 diabetes
J. Rahier et al.
DIABETES OBESITY & METABOLISM (2008)
Glucolipotoxicity:: Fuel excess and β-cell dysfunction
Vincent Poitout et al.
ENDOCRINE REVIEWS (2008)
Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes
D. R. Laybutt et al.
DIABETOLOGIA (2007)
Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes -: Many differences, few similarities
M Cnop et al.
DIABETES (2005)
分享论文
